McNeil R, Puri N, Boyd J, Mayer S, Hayashi K, Small W Understanding concurrent stimulant use among people on methadone: a qualitative study Drug Alcohol Rev, 2020. PubMed

Socías ME, Dong H, Wood E, Brar R, Richardson L, Hayashi K, Kerr T, Milloy MJ Trajectories of retention in opioid agonist therapy in a Canadian setting Int J Drug Policy, 2020. PubMed

Varghese N, Knight R, Gallagher L, Ti L Treatment of hepatitis C virus infection in marginalized populations Am J Nurs, 2020. PubMed

Lake S, Socías ME, Milloy MJ Evidence shows that cannabis has fewer relative harms than opioids CMAJ, 2020. PubMed

Wilson T, Brar R, Sutherland C, Nolan S Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report CMAJ, 2020. PubMed

Lake S, Kerr T, Buxton J, Walsh Z, Marshall BDL, Wood E, Milloy MJ Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians J Psychopharmacol, 2020. PubMed

Danilewitz M, McLean M High-dose buprenorphine for treatment of high potency opioid use disorder Drug Alcohol Rev, 2020. PubMed

Collins AB, Boyd J, Hayashi K, Cooper HLF, Goldenberg S, McNeil R Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: an ethnographic study Int J Drug Policy, 2020. PubMed

McAdam M, Brar R, Young S Initiation of injectable opioid agonist treatment in hospital: a case report Drug Alcohol Rev, 2020. PubMed

Randhawa P, Brar R, Nolan S Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market CMAJ, 2020. PubMed